Hepatic autoregulation: Response of glucose production and gluconeogenesis to increased glycogenolysis

American Journal of Physiology - Endocrinology and Metabolism

Volumn 292, Issue 5, 2007, Pages

  Staehr, Peter ^a   Hother Nielsen, Ole ^a   Beck Nielsen, Henning ^a   Roden, Michael ^b   Stingl, Harald ^c   Holst, Jens J ^d   Jones, Paul K ^e   Chandramouli, Visvanathan ^f   Landau, Bernard R ^f  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b HANUSCH HOSPITAL   (Austria)

^c UNIVERSITY OF VIENNA   (Austria)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e CASE WESTERN RESERVE UNIVERSITY   (United States)

^f CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Deuterium oxide; Galactose; Liver

Indexed keywords

GALACTOSE; GLUCOSE; GLUCOSE 1 PHOSPHATE; GLUCOSE 6 PHOSPHATE; INSULIN;

ADULT; ARTICLE; AUTOREGULATION; CONTROLLED STUDY; DIET RESTRICTION; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLYCOGEN LIVER LEVEL; GLYCOGEN SYNTHESIS; GLYCOGENOLYSIS; HUMAN; HUMAN EXPERIMENT; INSULIN BLOOD LEVEL; LIVER; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

ADULT; BLOOD GLUCOSE; C-REACTIVE PROTEIN; FASTING; GALACTOSE; GLUCAGON; GLUCONEOGENESIS; GLUCOSE; GLYCOGENOLYSIS; HUMANS; INSULIN; LIVER; MALE; MIDDLE AGED;

EID: 34247641209     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00411.2006     Document Type: Article

References (37)

1. Adkins A, Basu R, Persson M, Dicke B, Shah P, Vella A, Schwenk WF, Rizza R. Higher insulin concentrations are required to suppress gluconeogenesis than glycogenolysis in nondiabetic humans. Diabetes 52: 2213-2220, 2003.
2. Boden G, Chen X, Capulong E, Mozzolli M. Effects of free fatty acids on gluconeogenesis and autoregulation of glucose production in type 2 diabetes. Diabetes 50: 810-816, 2001.
3. Chandramouli V, Ekberg K, Schumann WC, Kalhan SC, Wahren J, Landau BR. Quantifying gluconeogenesis during fasting. Am J Physiol Endocrinol Metab 273: E1209-E1215, 1997.
4. Chandramouli V, Ekberg K, Schumann WC, Wahren J, Landau BR. Origins of the hydrogen bound to carbon 1 of glucose in fasting: signifi-cance in gluconeogenesis quantitation. Am J Physiol Endocrinol Metab 277: E717-E723, 1999.
5. Chen X, Iqbal N, Boden G. The effects of free fatty acids on gluconeogenesis and glycogenolysis in normal subjects. J Clin Invest 103: 365-372, 1995.
6. Cohen RM, Segal S. Galactose metabolism and its regulation. Metabolism 22: 627-642, 1973.
7. Edgerton DS, Cardin S, Emshwiller M, Neal D, Chandramouli V, Schumann WC, Landau BR, Rossetti L, Cherrington AD. Small increases in insulin inhibit hepatic glucose production solely caused by an effect on glycogen metabolism. Diabetes 50: 1872-1882, 2001.
8. Fosgerau K, Mittelman SD, Sunehag A, Dea MK, Lundgren K, Bergman RN. Lack of hepatic "interregulation" during inhibition of glycogenolysis in a canine model. Am J Physiol Endocrinol Metab 281: E375-E383, 2001.
9. Fried R, Beckmann N, Keller U, Ninnis R, Stalder G, Seelig J. Early glycogenolysis and late glycogenesis in human liver after intravenous administration of galactose. Am J Physiol Gastrointest Liver Physiol 270: G14-G19, 1996.
10. Gannon MC, Khan MA, Nuthall FQ. Glucose appearance rate after the ingestion of galactose. Metabolism 50: 93-98, 2001.
11. Grodsky GM, Bates AA, Benett LL, Voella C, McWilliams NB, Smith DF. Effects of carbohydrate on secretion of insulin from isolated rat pancreas. Am J Physiol 205: 638-644, 1963.
12. Haesler E, Schneiter P, Temler E, Jéquier E, Tappy L. Effects of lactate infusion on hepatic gluconeogenesis and glycogenolysis. Clin Physiol 15: 581-595, 1995.
13. Holst JJ. Molecular heterogeneity of glucagon in normal subjects and in patients with glucagon producing tumors. Diabetologia 24: 359-365, 1983.
14. 3H glucose infusion. Diabetologia 33: 603-610, 1990.
15. Hundal RS, Krssak M, Dufour S, Laurent D, Lebon V, Chandramouli V, Inzucchi SE, Schumann WC, Petersen KF, Landau BR, Shulman GI. Mechanism by which metformin reduces glucose production in type 2 diabetes. Diabetes 49: 2063-2069, 2000.
16. Jahoor F, Peters EJ, Wolfe RR. The relationship between gluconeogenic substrate supply and glucose production in humans. Am J Physiol Endocrinol Metab 258: E288-E296, 1990.
17. Jenssen T, Nurjhan N, Consoli A, Gerich JE. Failure of substrate-induced gluconeogenesis to increase overall glucose appearance in normal humans. J Clin Invest 86: 489-497, 1990.
18. Kubota M, Virkamäki A, Yki-Järvinen H. Ethanol stimulates glycogenolysis in livers from fed rats. Proc Soc Exp Biol Med 201: 114-118, 1992.
19. 2H nuclear magnetic resonance spectroscopy. Diabetes 52: 2475-2482, 2003.
20. Kutner MH, Nachtsheim CJ, Neter J, Li W. Applied Linear Statistical Models. New York: McGraw-Hill/Irwin, 2005, p. 741-742, 897.
21. Lam KT, Carpentier A, Lewis GF, van de Werve G, Fantus IG, Giacca A. Mechanisms of free fatty acid induced increase in hepatic glucose production. Am J Physiol Endocrinol Metab 284: E863-E873, 2003.
22. Landau BR. Problems with the assumed biochemical basis for estimating hepatic glycogen turnover using glucuronide formation and labeled galactose. Metabolism 49: 1374-1375, 2000.
23. Landau BR. Methods for measuring glycogen cycling. Am J Physiol Endocrinol Metab 281: E413-E419, 2001.
24. Landau BR, Bartsch GE. Estimation of pathway contributions to glucose metabolism and the transaldolase reactions. J Biol Chem 241: 741-749, 1966.
25. Landau BR, Wahren J, Chandramouli V, Schumann WC, Ekberg K, Kalhan SC. Contributions of gluconeogenesis to glucose production in the fasted state. J Clin Invest 98: 378-385, 1996.
26. Magnusson I, Chandramouli V, Schumann WC, Kumaran K, Wahren J, Landau BR. Pentose pathway in human liver. Proc Natl Acad Sci USA 85: 4682-4685, 1988.
27. Puhakainen I, Koivisto VA, Yki-Järvinen H. No reduction in total hepatic glucose output by inhibition of gluconeogenesis with ethanol in NIDDM patients. Diabetes 40: 1319-1327, 1991.
28. Radziuk J, Pye S. Hepatic glucose uptake, gluconeogenesis and the regulation of glycogen synthesis. Diabetes Metab Res Rev 17: 250-272, 2001.
29. Rothman DL, Magnusson I, Katz LD, Schuman RG, Shulman GI. Quantitation of hepatic glycogenolysis and gluconeogenesis in fasting humans with 13C NMR. Science 254: 573-576, 1991.
30. 2O administration. Anal Biochem 297: 195-197, 2001.
31. Shiota M, Jackson PA, Bischoff H, McCaleb M, Scott M, Monohan M, Neal DW, Cherrington AD. Inhibition of glycogenolysis enhances gluconeogenic precursor uptake by the liver of conscious dogs. Am J Physiol Endocrinol Metab 273: E866-E879, 1997.
32. Sidbury JB Jr. Investigations and speculations in the pathogenesis of galactosemia. In: Galactosemia, edited by Hsia DY-Y. Springfield, IL: Charles C. Thomas, 1969, p. 13-29.
33. Stingl H, Chandramouli V, Schumann WC, Brehm A, Nowotny P, Waldhäusl W, Landau BR, Roden M. Changes in hepatic glycogen cycling during a glucose load in healthy humans. Diabetologia 49: 360-368, 2006.
34. Sunehag AL, Haymond MW. Splanchnic galactose extraction is regulated by coingestion of glucose in humans. Metabolism 51: 827-832, 2002.
35. Tappy L. Regulation of hepatic glucose production in healthy subjects and patients with non-insulin dependent diabetes mellitus. Diabetes Metab 21: 233-240, 1995.
36. Timmer JF, Casazza GA, Horning ME, Brooks GA. Autoregulation of glucose production in men with a glycerol load during rest and exercise. Am J Physiol Endocrinol Metab 280: E657-E668, 2001.
37. Wolfe RR. Radioactive and Stable Isotope Tracers in Biomedicine. New York: Wiley-Liss, 1992, p. 132.